Robert I. Nicholson - Concepedia

Author

Robert I. Nicholson

Also Known As

Gee, Julia, Nicholson, Robert Ian, R I Nicholson, R NICHOLSON, R Nicholson, R. I. NICHOLSON, R. I. Nicholson, R. NICHOLSON, R. Nicholson, R.I Nicholson

383

Publications

23.7K

Citations

H-Index

174

Concepts

All Affiliations

Tenovus Cancer Care Nottingham City Hospital Cardiff University University of Wales AstraZeneca (United Kingdom)

About

Robert I. Nicholson is an author at Tenovus Cancer Care specializing in medicine, breast cancer, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	63	125	12.6K
2	Engineering	14	15	983
3	Health Sciences	4	4	414
4	Business	1	1	93
5	Education	1	1	19

Robert I. Nicholson

188

Publications

18.5K

Citations

H-Index

Page 1

	Year	Citations
A prognostic index in primary breast cancer J. L. Haybittle, R.W. Blamey, C.W. Elston, British Journal of Cancer Breast OncologyMedicinePathologyPrognostic IndexCancer Registration	1982	714
Expression and amplification of cyclin genes in human breast cancer. Michael F. Buckley, Kimberley J. E. Sweeney, John A. Hamilton, PubMed	1993	674
Expression of luminal and basal cytokeratins in human breast carcinoma Dalia M. Abd El‐Rehim, Sarah E. Pinder, Claire E. Paish, The Journal of Pathology Tumor BiologyBreast OncologyOncologyEr PositivityMedicine	2004	593
Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells Janice M. Knowlden, Iain R. Hutcheson, Helen E. Jones, Endocrinology	2003	525
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival Jennifer Law, Golareh Habibi, Kaiji Hu, Cancer Research	2008	404
New Arylthioindoles: Potent Inhibitors of Tubulin Polymerization. 2. Structure−Activity Relationships and Molecular Modeling Studies Gabriella Martino, Michael Edler, Giuseppe La Regina, Journal of Medicinal Chemistry Pharmaceutical ScienceChemical BiologyPharmaceutical ChemistryMedicinal ChemistryAnti-cancer Agent	2006	356
Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor–Positive Phenotype Emad A. Rakha, Maysa E. El‐Sayed, Andrew R. Green, Journal of Clinical Oncology	2007	323
Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen Antoni Hurtado, Kelly A. Holmes, Timothy R. Geistlinger, Nature Breast OncologyOestrogen Receptor–pax2MedicineHormonal ReceptorBreast Cancer	2008	315
Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells Helen E. Jones, Lindy Goddard, Julia M.W. Gee, Endocrine Related Cancer Human BreastBreast OncologyOncologyMedicineReceptor Tyrosine Kinase	2004	298
Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Joan Albanell, Jordi Codony‐Servat, Federico Rojo, PubMed Epidermal Growth FactorExtracellular Signal-regulated KinasesPathologyNeck Squamous CarcinomaGrowth Factor Alpha	2001	275

Page 1